Foster Dykema Cabot & Partners’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.4M Sell
43,111
-825
-2% -$570K 1.87% 16
2025
Q4
$25.1M Buy
43,936
+1,872
+4% +$1.09M 1.54% 23
2025
Q3
$25.6M Buy
42,064
+49
+0.1% +$27.8K 1.68% 19
2025
Q2
$21M Sell
42,015
-349
-0.8% -$172K 1.48% 23
2025
Q1
$21.7M Sell
42,364
-454
-1% -$217K 1.74% 21
2024
Q4
$20.1M Buy
42,818
+2,898
+7% +$1.46M 1.57% 25
2024
Q3
$21.1M Sell
39,920
-593
-1% -$290K 1.77% 23
2024
Q2
$17.7M Buy
40,513
+1,891
+5% +$864K 1.58% 26
2024
Q1
$18.5M Buy
38,622
+759
+2% +$350K 1.72% 25
2023
Q4
$17.7M Buy
+37,863
New +$17.7M 1.88% 20

Other funds holding NOC

Foster Dykema Cabot & Partners's NOC Position: Q1 2026 in Review

Foster Dykema Cabot & Partners reduced its Northrop Grumman (NOC) stake by 1.9% in Q1 2026, selling an estimated $570K and leaving 43,111 shares worth $29.4M. The position accounts for 1.87% of the portfolio, ranked #16.

Foster Dykema Cabot & Partners first reported a position in NOC in Q4 2023 and has held it in 10 quarters since. 1,875 funds tracked by Wall St. Rank hold NOC as of Q1 2026.

  • Foster Dykema Cabot & Partners held 43,111 shares of Northrop Grumman worth $29.4M as of Q1 2026.
  • Foster Dykema Cabot & Partners sold 825 Northrop Grumman shares in Q1 2026, an estimated $570K.
  • Northrop Grumman made up 1.87% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #16 holding.
  • Foster Dykema Cabot & Partners first reported a position in Northrop Grumman in Q4 2023 and has held it in 10 quarters since.
  • 1,875 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.